Application of chemometric algorithms to MALDI mass spectrometry imaging of pharmaceutical tablets.
暂无分享,去创建一个
Adel Hafiane | Aladine Chetouani | Rachid Jennane | R. Jennane | Y. Ginot | A. Hafiane | M. Boiret | Mathieu Boiret | Yves-Michel Ginot | Yoann Gut | Laurent Bultel | Tristan Renaud | Laurent Bultel | A. Chetouani | Y. Gut | T. Renaud
[1] Pierre Margot,et al. Identification of pharmaceutical tablets by Raman spectroscopy and chemometrics. , 2010, Talanta.
[2] Brendan Prideaux,et al. Mass spectrometry imaging for drug distribution studies. , 2012, Journal of proteomics.
[3] F. Muzzio,et al. Characterization of pharmaceutical powder blends using in situ near-infrared chemical imaging , 2014 .
[4] José Manuel Amigo,et al. Direct quantification and distribution assessment of major and minor components in pharmaceutical tablets by NIR-chemical imaging. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[5] R. Caprioli,et al. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.
[6] Renfu Lu,et al. Hyperspectral and multispectral imaging for evaluating food safety and quality , 2013 .
[7] P J Cullen,et al. Recent applications of Chemical Imaging to pharmaceutical process monitoring and quality control. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] Markus Stoeckli,et al. Molecular imaging of amyloid beta peptides in mouse brain sections using mass spectrometry. , 2002, Analytical biochemistry.
[9] C. De Bleye,et al. Development of a quantitative approach using surface-enhanced Raman chemical imaging: first step for the determination of an impurity in a pharmaceutical model. , 2014, Journal of pharmaceutical and biomedical analysis.
[10] H. Wariishi,et al. In situ metabolomic mass spectrometry imaging: recent advances and difficulties. , 2012, Journal of proteomics.
[11] Karsten Mäder,et al. Pharmaceutical applications of magnetic resonance imaging (MRI). , 2005, Advanced drug delivery reviews.
[12] José M. Bioucas-Dias,et al. Vertex component analysis: a fast algorithm to unmix hyperspectral data , 2005, IEEE Transactions on Geoscience and Remote Sensing.
[13] R. Tauler,et al. Combining hard- and soft-modelling to solve kinetic problems , 2000 .
[14] F. R. Lauritsen,et al. Fast and direct recognition of the active ingredients in tablets using hot cell membrane inlet mass spectrometry , 2010 .
[15] P. Chaurand,et al. Sublimation of new matrix candidates for high spatial resolution imaging mass spectrometry of lipids: enhanced information in both positive and negative polarities after 1,5-diaminonapthalene deposition. , 2012, Analytical chemistry.
[16] Richard M. Caprioli,et al. MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue. , 2008, Analytical chemistry.
[17] D. Jouan-Rimbaud Bouveresse,et al. Independent components analysis with the JADE algorithm , 2012 .
[18] M. Fathi,et al. Desorption electrospray ionization mass spectrometry: direct toxicological screening and analysis of illicit Ecstasy tablets. , 2006, Rapid communications in mass spectrometry : RCM.
[19] G. Morrison,et al. Chemical imaging in biology and medicine using ion microscopy , 1991 .
[20] Romà Tauler,et al. Local rank exploratory analysis of evolving rank-deficient systems , 2004 .
[21] Liam A. McDonnell,et al. Imaging mass spectrometry data reduction: Automated feature identification and extraction , 2010, Journal of the American Society for Mass Spectrometry.
[22] Patrik O. Hoyer,et al. Non-negative Matrix Factorization with Sparseness Constraints , 2004, J. Mach. Learn. Res..
[23] M. Stoeckli,et al. Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.
[24] Liam A. McDonnell,et al. Imaging mass spectrometry statistical analysis. , 2012, Journal of proteomics.
[25] Jean-Michel Roger,et al. Application of independent component analysis on Raman images of a pharmaceutical drug product: pure spectra determination and spatial distribution of constituents. , 2014, Journal of pharmaceutical and biomedical analysis.
[26] M. Clench,et al. Direct analysis of pharmaceutical tablet formulations using Matrix-Assisted Laser Desorption/Ionisation Mass Spectrometry Imaging. , 2010, Rapid communications in mass spectrometry : RCM.
[27] Cheng-Huang Lin,et al. Rapid drug-screening of clandestine tablets by MALDI-TOF mass spectrometry. , 2005, Talanta.
[28] Liam A. McDonnell,et al. Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma , 2011, PloS one.
[29] R. Murphy,et al. Sublimation as a method of matrix application for mass spectrometric imaging , 2007, Journal of the American Society for Mass Spectrometry.
[30] W. Skinner,et al. Time‐of‐flight secondary‐ion mass spectrometry for the surface characterization of solid‐state pharmaceuticals , 2007, The Journal of pharmacy and pharmacology.
[31] Romà Tauler,et al. MCR-ALS GUI 2.0: New features and applications , 2015 .